Britain can produce cannabis at scale - yet I find it unbelievable we remain reliant on approximately 90% imports …. it is a direct failure of the Home Office.
British producers are held to strict standards, investing millions, while imports are allowed in without the same scrutiny.
That is not regulation… it is a clear and damaging double standard.
Cannabis is a proven growth sector.
Jobs
Investment
Revenue , all being lost because of government inaction.
This is a policy failure and it must be urgently addressed.
@GlassPharms
A milestone moment for #GlassPharms 📦
Last Friday, we shipped our 100th weekly order of #medicalcannabis flower.
2 years ago, we shipped our first-ever batch of bulk flower.
Now, our weekly shipments are 10x the volume.
Here’s to the next 100 shipments! 📈
Glass Pharms featured on @ITV, @BBCiPlayer & @S4C 🇬🇧
Supporting the conversation on the future of pharmaceutical cannabis in the UK.
🎬 Watch now from 06:56–09:57
🔗 S4C https://t.co/RPJGsD4HBE
🔗 BBC https://t.co/8vUFSyqQKb
#GlassPharms#MedicalCannabis#MadeInBritain
Rooted in nature this festive season! 🎄
Proud of the progress being made in UK #medicalcannabis and grateful to everyone helping move the industry forward.
Wishing you all a peaceful festive break and a healthy year ahead! 🎆
#christmas#newyear#glasspharms#glasspharmsuk
Glass Pharms is revolutionizing medical cannabis in the UK:
🤖 Patent-pending robotic cultivation system
⚡ 40% less power than traditional indoor grows
🧬 Tissue culture genetics = zero variation, pharma-grade consistency
🌿 21 different cultivars for diverse medical needs
📦 1,700kg annual production capacity
♻️ World's first carbon-negative cannabis farm
🏭 2.4 hectares - UK's largest facility
💰 £26M investment
Powered by food waste from neighboring anaerobic digestion plant. Uses AI, remote sensors & automation for pharmaceutical standards.
Supplying Releaf & Mamedica clinics. 100K patients by end of 2025.
Future of medical marijuana production. 🇬🇧🌿
#MedicalCannabis #AgriTech"
Congrats to the @GlassPharms team on their latest supply partnerships and the launch of a new premium range. 🌿🚀
Details below from @BofC_Global
https://t.co/PBbtN9X48g
UK-based medical cannabis cultivator @GlassPharms has announced a new supply agreement with Integro Clinic & IPS Pharmacy to provide them with a new premium range of Glass Pharms-branded CBPMs.
https://t.co/UUYif8Zx35
'Calls to grow UK economy with cannabis as Snoop Dogg invests in ‘untapped’ market'
Companies and MPs have said legal #medicalcannabis cultivators could provide a ‘huge opportunity’ for economic growth and health benefits 🍃
[@LBC / @mamedicauk]
https://t.co/CK2FJrWZCu
@GlassPharms wow wow wow. Extremely happy with First Class Funk, Glitter Bomb & BlackBerry Sour. Packaging is fantastic, flower is incredible. 10/10.
We’re proud to share that we’ve officially planted our 1000th batch of #medicalcannabis! 🌱
A huge thank you to our dedicated team for upholding the highest standards of quality and care.
Here’s to the next thousand! 🪴
🔗https://t.co/BpdtIJMLpV
#glasspharms#madeinbritain
@GlassPharms The fact it’s all produced and handled in the UK, and non irradiated, at the price point is great. Don’t get me wrong I’d still like to see less than £200 for 30g but at £207 it’s competitive and I can see these flowers getting very popular. Also, amazing packaging.
Glass Pharms has announced a new supply deal, introducing a new line of affordable, entirely UK-produced products.
3 new additions to the ‘EcoCann Access’ range, derived from @GlassPharms sustainably grown flower, will now be prescribed via @CB1Medical.
https://t.co/9NoYnwCBbM